NNZ-4921

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNNZ-4921
Drug Alias Nameneuronal regeneration peptides (CuroNZ)NNZ-4921
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationSpinal Cord InjuriesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandNew Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuren Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNerve DegenerationSpinal Cord InjuriesMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A